![]() |
市场调查报告书
商品编码
1700020
2032 年对氨基苯酚预测:按形态、等级、销售管道、应用和地区进行的全球分析Para Aminophenol Market Forecasts to 2032 - Global Analysis By Form (Powder, Crystals, and Liquids), Grade, Sales Channel, Application and By Geography |
根据 Stratistics MRC 的数据,全球对氨基苯酚市场预计在 2025 年达到 30.1 亿美元,到 2032 年将达到 46.3 亿美元,预测期内的复合年增长率为 6.3%。
对氨基苯酚(PAP)是一种有机化合物,化学式为C6H7NO。它是一种结晶质固体,主要用于製造乙酰胺酚(乙酰胺酚),一种常见的止痛药和退烧药。 PAP也用于製造染料和颜料,特别是在纺织业中,以及製造用于摄影和影像处理的化学品。由于其用途广泛,包括药品、化学品和化妆品,它是各种行业的重要原料。
对乙酰胺酚的需求不断增加
对乙酰胺酚,也称为乙酰胺酚,是一种常用的非处方止痛退烧药。对乙酰胺酚的需求是由于慢性疾病和与疼痛管理相关的病症(例如关节炎和术后疼痛)的发病率不断上升所致。随着人口老化和对疼痛管理方法的了解不断加深,对乙酰胺酚的消费量也增加。全球约 80% 的 PAP 产量由对乙酰胺酚製成,因此对乙酰胺酚市场直接影响 PAP 需求。
原物料价格波动
原物料价格波动是对氨基苯酚(PAP)市场的主要限制因素。这是因为苯胺和其他化学前驱等关键投入的成本波动直接影响生产成本。价格波动为製造商带来了不确定性,影响了他们维持一致定价策略的能力。这种不可预测性也可能迫使公司调整利润率、提高产品价格并推迟生产计划。此外,对不同经济状况地区供应商的依赖进一步加剧了挑战,使企业难以长期有效地规划和管理生产成本。
製药业的扩张
对乙酰胺酚(乙酰胺酚)等非处方药的需求不断增加,而这些药物是由 PAP 生产的,这是由于全球(尤其是新兴国家)的医疗保健需求不断增长。解热镇痛疗法的日益普及进一步推动了製药製造业对 PAP 的需求。随着医疗保健基础设施的发展和药品的普及,开发中国家对 PAP 的使用也增加。预计此类扩张将支持 PAP 市场製药领域的持续成长。
供应链中断
由于供应链中断,对氨基苯酚 (PAP) 市场面临重大挑战。供应链中断可能会损害原材料的可得性、推迟生产计划并影响分销网络。新冠肺炎疫情、自然灾害和地缘政治紧张局势等疫情可能会导致必需化学品前驱物和最终产品的运输延误。这些中断将导致前置作业时间增加、营运成本上升,甚至可能导致市场上的产品减少。此外,製造商可能难以以可负担的成本找到可靠的原材料来源,这可能会影响他们满足需求和维持利润的能力。
COVID-19 疫情导致供应链延迟、生产设施暂时关闭,影响了对氨基苯酚 (PAP) 市场,影响了产量。然而,随着人们寻求非处方药来减轻发烧和疼痛,对药物 PAP(特别是对乙酰胺酚(乙酰胺酚))的需求激增。儘管製药业表现出韧性,但纺织和染料产业面临放缓。预计疫情后的復苏将推动 PAP 市场稳定成长。
电子商务领域预计将成为预测期内最大的领域
由于製造商和供应商更容易获得原材料,预计电子商务领域将在预测期内占据最大的市场占有率。这个线上平台为企业提供了一种便捷的方式来采购用于製药、化学和化妆品应用的 PAP。电子商务还透过促进直接贸易、降低分销成本和扩大客户范围来提高市场准入度,特别是对于中小型企业而言,从而促进 PAP 行业的整体成长。
预计在预测期内,製药业将实现最高的复合年增长率。
由于对乙酰胺酚(乙酰胺酚)的需求不断增加,预计预测期内製药业将出现最高增长率,乙酰氨基酚被广泛用于止痛药和退烧药。随着全球尤其是新兴市场的医疗保健需求不断增长,用于生产止痛药的 PAP 的需求也日益增加。此外,医疗保健基础设施的进步和非处方药取得管道的增加进一步推动了製药业对 PAP 的需求。
在预测期内,由于工业化快速发展、製药生产扩张以及纺织和化妆品行业的扩张,预计亚太地区将占据最大的市场占有率。中国和印度等国家对乙酰胺酚的需求不断增加将促进製药业的发展,而染料和颜料中 PAP 的使用量不断增加将支持纺织和个人护理行业的发展。此外,具有成本效益的製造和庞大的消费群也促进了该地区 PAP 市场的强劲成长。
预计北美地区在预测期内将呈现最高的复合年增长率。这是由于对止痛药和退烧药的需求不断增长,推动了 PAP 的消费。此外,北美成熟的製药业将有助于市场扩张,而纺织品和化妆品对高级染料的需求不断增长将进一步推动成长。这一趋势正在加强该地区在全球 PAP 市场的影响力。
According to Stratistics MRC, the Global Para Aminophenol Market is accounted for $3.01 billion in 2025 and is expected to reach $4.63 billion by 2032 growing at a CAGR of 6.3% during the forecast period. Para-Aminophenol (PAP) is an organic compound with the chemical formula C6H7NO. It is a crystalline solid primarily used in the production of acetaminophen (paracetamol), a common analgesic and antipyretic. PAP is also employed in the manufacturing of dyes and pigments, especially in the textile industry, and in the production of certain chemicals used in photography and imaging. Its versatile applications in pharmaceuticals, chemicals, and cosmetics make it a critical raw material in various industries.
Growing demand for acetaminophen
Acetaminophen, also known as paracetamol, is widely used as an over-the-counter medication for pain relief and fever reduction. The need for acetaminophen is being driven by the rising incidence of chronic illnesses and pain-management-related ailments such arthritis and post-operative pain. Increased acetaminophen consumption is also a result of the aging population and growing understanding of pain management options. Since acetaminophen is made from roughly 80% of PAP produced worldwide, the market for acetaminophen has a direct impact on PAP demand.
Volatility in raw material prices
Volatility in raw material prices is a significant restraint for the Para-Aminophenol (PAP) market, as fluctuations in the cost of key inputs, such as aniline and other chemical precursors, directly affect production costs. Price instability can lead to uncertainty for manufacturers, impacting their ability to maintain consistent pricing strategies. This unpredictability may also force companies to adjust their profit margins, increase product prices, or delay production schedules. Additionally, reliance on suppliers from different regions, with varying economic conditions, further exacerbates the challenge, making it difficult for companies to plan and manage production costs effectively in the long term.
Expansion of pharmaceutical industry
The increased demand for over-the-counter drugs like acetaminophen (paracetamol), which is produced from PAP, is a result of the growing healthcare demands worldwide, especially in emerging nations. The necessity for PAP in pharmaceutical manufacture is further increased by the rising popularity of fever-reducing and pain-management therapies. PAP use is also increased in developing nations due to the development of healthcare infrastructure and increased availability to pharmaceuticals. This expansion is expected to support continued growth in the pharmaceutical segment of the PAP market.
Supply chain disruptions
The para-aminophenol (PAP) market is severely challenged by supply chain interruptions, which can impair raw material availability, postpone manufacturing plans, and have an impact on distribution networks. Transportation of essential chemical precursors and final goods may be delayed by occurrences such as the COVID-19 pandemic, natural disasters, or geopolitical tensions. Increased lead times, greater operating expenses and perhaps fewer products available on the market are the results of these disruptions. Additionally, manufacturers might have trouble finding reliable sources of raw materials at affordable costs, which could affect their capacity to satisfy demand and stay profitable.
The COVID-19 pandemic disrupted the Para-Aminophenol (PAP) market by causing supply chain delays and temporary closures of manufacturing facilities, affecting production volumes. However, the demand for PAP in pharmaceutical applications, particularly for acetaminophen (paracetamol), surged as people sought over-the-counter medications for fever and pain relief. The pharmaceutical sector showed resilience, while the textile and dye industries faced slowdowns. Post-pandemic recovery is expected to drive steady growth in the PAP market.
The E-commerce segment is expected to be the largest during the forecast period
The E-commerce segment is expected to account for the largest market share during the forecast period driven by enabling easier access to raw materials for manufacturers and suppliers. Online platforms offer a convenient way for businesses to procure PAP for pharmaceutical, chemical, and cosmetic applications. E-commerce also facilitates direct transactions, reduces distribution costs, and widens the customer base, particularly for small and medium-sized enterprises, contributing to increased market accessibility and overall growth in the PAP industry.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate due to the rising demand for acetaminophen (paracetamol), a widely used analgesic and antipyretic. As healthcare needs rise globally, especially in emerging markets, the demand for PAP to produce pain relief medications continues to increase. Additionally, advancements in healthcare infrastructure and expanding over-the-counter drug accessibility further boost the demand for PAP in the pharmaceutical industry.
During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by rapid industrialization, growing pharmaceutical production, and expanding textile and cosmetic industries. The rising demand for acetaminophen in countries like China and India fuels the pharmaceutical sector, while the increasing use of PAP in dyes and pigments supports the textile and personal care industries. Moreover, cost-effective manufacturing and a large consumer base further contribute to the robust growth of the PAP market in this region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to the growing demand for pain relievers and fever-reducing medications boosts PAP consumption. Additionally, North America's well-established pharmaceutical sector fosters market expansion, while increasing demand for advanced dyes in textiles and cosmetics further drives growth. This trend strengthens the region's influence in the global PAP market.
Key players in the market
Some of the key players in Para Aminophenol Market include BASF SE, Lanxess AG, Merck Group, Eastman Chemical Company, Sumitomo Chemical Co., Ltd., Hunan Lerk Pharmaceutical Co., Ltd., Aarti Industries Ltd., Arkema Group, Daiichi Sankyo Co., Ltd., Chongqing Changfeng Chemical Co., Ltd., Anhui Bayi Chemical Industry Co., Ltd., Jiangsu Huanxin Pharmaceutical Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Lianyungang Dongjin Chemical Co., Ltd., and Taizhou Zhongtai Chemical Co., Ltd.
In January 2025, BASF's Personal Care business is launching a new ingredient, VitaGuard (R)A to capture the continuous market demand for retinol, while reinforcing its position as a Hero ingredient in cosmetics. This latest innovation is based on the encapsulation of free retinol. VitaGuard(R) A was developed using patented solid lipid particles, protecting retinol from degradation, limiting skin irritation and allowing better skin bioavailability for improved cosmetic efficacy.
In January 2025, Eastman introduced the latest innovation in its sustainable fiber portfolio today at Heimtextil trade fair in Frankfurt, Germany. Eastman Naia(TM) Renew cellulosic fiber for fill applications expands beyond the brand's success in bedding and towels. The fiber transforms comforters and quilts with breathable comfort, luxurious softness and unparalleled ease of care.